Research on Pancreas Disease in Irish Farmed Salmon 2004/2005 – Current and Future Initiatives

Abstract

Pancreas Disease is the most significant single infectious disease affecting marine salmon farms in Ireland. The first epidemiological studies of Pancreas Disease (PD) in Ireland in the early 1990’s indicated that significant losses occurred in farmed Atlantic salmon in their first year at sea on some individual farms (Menzies et al., 1996). A serological survey for the presence of Salmon Pancreas Disease Virus (SPDV) antibody in 1996 revealed that 53% of Irish sites were positive, but that not all positive sites had recognised clinical signs of PD. This indicated a relatively low incidence and severity of PD at that time (McLoughlin et al., 1998) and this pattern persisted throughout the remainder of the 1990’s. In 2002, a serious increase in both the incidence and severity of PD was reported on farmed Atlantic salmon marine sites in Ireland. An epidemiological survey of Irish sites for 2002 revealed that 59% of sites reported an outbreak of PD, with mortalities averaging 12% (range 1 – 42%; McLoughlin et al., 2003). A recent study using data collected for 2003 and 2004 indicated that PD occurred in 62% and 86% of sites respectively. The average mortality due to PD on affected farms was 18.8% in 2003 and 14.8% in 2004. In response to these significant losses due to PD a range of research initiatives was launched in Ireland and was supported by the Marine Institute. This document gives an overview of the most recent findings from the current projects, carried out in 2004/2005 and also provides an overview of the various actions in Scotland and Norway, where PD has also become a disease of economic significance in salmon aquaculture.